NCT04438382 2026-02-27
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Eastern Cooperative Oncology Group
Phase 2 Terminated
Clinical Trials
12 trialsNCT07202052 2025-10-07
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Monash University
Phase 2/3 Recruiting
NCT07202065 2025-10-07
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
Monash University
Phase 2/3 Recruiting
NCT04728425 2025-04-27
MG_SCIG
University Health Network, Toronto
Phase 2 Completed
NCT06064279 2024-09-19
HAITEN-ICI
VA Office of Research and Development
Phase 1/2 Withdrawn
NCT00033293 2023-04-18
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Children's Oncology Group
Phase 3 Completed
NCT04101578 2021-08-23
Clinical Prognosis and Progression of Myasthenia Gravis Patients
Da, Yuwei, M.D.
Unknown
NCT02398994 2016-07-20
STRIVE
Guy's and St Thomas' NHS Foundation Trust
Phase 3 Terminated
NCT01545518 2014-09-01
IVIG Treatment for Refractory Immune-Related Adult Epilepsy
Emory University
Phase 2 Terminated
NCT00547365 2013-09-19
Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
University of Tennessee
Phase 1/2 Completed
NCT01179893 2010-08-11
Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis
University Health Network, Toronto
Phase 4 Completed
NCT00294476 2006-10-12
IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma
GammaCan
Phase 2 Unknown